The Real GLP-1 Debate: Is Obesity A ‘Disease?’

Will the Trump Administration rescind the Medicare anti-obesity medication coverage proposed rule? Past comments suggest the answer is not clear cut. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Medicare

More from Market Access